Science 37 has been recognized with the prestigious Frost & Sullivan Company of the Year Award in the global decentralized clinical trials (DCT) industry. This acknowledgment highlights Science 37's accomplishments, and solidifies its role as an industry leader, as it continues to transform clinical trial conduct through its Virtual Site and Patient Recruitment solutions.

Frost & Sullivan's Best Practices Company of the Year Award is bestowed upon the company that exhibits market-leading performance, visionary innovation and unmatched customer care in their respective industries. The receipt of this prestigious award highlights Science 37’s dedication to accelerating clinical research by enabling universal trial access for patients.

To learn more about Frost & Sullivan’s analysis of Science 37, fill out the form.

Science 37 has been recognized with the prestigious Frost & Sullivan Market Leadership Award in the global decentralized clinical trials (DCT) industry. This acknowledgment highlights Science 37's accomplishments, and solidifies its role as an industry leader, as it continues to transform clinical trial conduct through the Metasite™.

Frost & Sullivan's Best Practices Market Leadership Award is bestowed upon companies that exhibit outstanding performance and visionary approaches in their respective industries. The receipt of this prestigious award highlights Science 37’s dedication to accelerating clinical research by enabling universal trial access for patients.

Science 37's unique approach is a virtual site, or Metasite, which enables patients to participate in clinical trials from the comfort of their homes. 

To learn more about Frost & Sullivan’s analysis of the Metasite, fill out the form.

Science 37’s 2nd Annual The Future of Clinical Trials Survey shares how the acceleration and adoption of decentralized clinical trials will reshape the research landscape in 2023.

Download the report now to read the important study findings and new data on the evolution of clinical trials.

Learn more about:

• What's next in the decentralization of clinical trials and how clinical research teams can adapt.
• New data on the most prevalent therapeutic areas, study phases, perceived benefits/challenges, and more.
• A look into the attitudes and progress towards implementing diversity initiatives.

Register now to access the report.

We know that clinical research is undergoing transformation across the board—but how will it impact CNS (central nervous system) clinical trials?

Science 37® has surveyed research executives at trial-sponsoring organizations, uncovering pivotal insights on how clinical research trends are impacting the CNS space.

In this report, you will learn

• New research trends that are impacting CNS clinical trials
• How decentralized and agile trials are changing the space
• How wearables and sensors are being used in CNS trials

Fill out the form to download your copy of the How Agile Clinical Trials are Impacting CNS Research report